Gland Pharma shares fall 6% as ex-promoter likely sells stake in block deals

Shares of Gland Pharma fell up to 6% to the day’s low of Rs 1,745 on BSE in Tuesday’s trade after entities related to ex-promoter Dr Ravi Penmetsa likely sold 5.5% equity in the company. Large block deals of nearly 91 lakh shares were reported today in which shares worth about Rs 1,600 crore changed … Read more

Hot Stocks: Brokerage views on Gland Pharma, Bharat Forge, M&M and CG Consumer

Brokerage firm Morgan Stanley maintained an Equal Weight rating on Crompton Greaves Consumer and an overweight rating on Bharat Forge. Jefferies recommended a hold rating on M&M and BofA Securities recommended a buy on Gland Pharma. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Morgan Stanley on … Read more